'If not TB, what could it be?' Chest X-ray findings from the 2016 Kenya Tuberculosis Prevalence Survey.


Journal

Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353

Informations de publication

Date de publication:
06 2021
Historique:
received: 31 08 2020
revised: 20 12 2020
accepted: 23 12 2020
pubmed: 29 1 2021
medline: 14 7 2021
entrez: 28 1 2021
Statut: ppublish

Résumé

The prevalence of diseases other than TB detected during chest X-ray (CXR) screening is unknown in sub-Saharan Africa. This represents a missed opportunity for identification and treatment of potentially significant disease. Our aim was to describe and quantify non-TB abnormalities identified by TB-focused CXR screening during the 2016 Kenya National TB Prevalence Survey. We reviewed a random sample of 1140 adult (≥15 years) CXRs classified as 'abnormal, suggestive of TB' or 'abnormal other' during field interpretation from the TB prevalence survey. Each image was read (blinded to field classification and study radiologist read) by two expert radiologists, with images classified into one of four major anatomical categories and primary radiological findings. A third reader resolved discrepancies. Prevalence and 95% CIs of abnormalities diagnosis were estimated. Cardiomegaly was the most common non-TB abnormality at 259 out of 1123 (23.1%, 95% CI 20.6% to 25.6%), while cardiomegaly with features of cardiac failure occurred in 17 out of 1123 (1.5%, 95% CI 0.9% to 2.4%). We also identified chronic pulmonary pathology including suspected COPD in 3.2% (95% CI 2.3% to 4.4%) and non-specific patterns in 4.6% (95% CI 3.5% to 6.0%). Prevalence of active-TB and severe post-TB lung changes was 3.6% (95% CI 2.6% to 4.8%) and 1.4% (95% CI 0.8% to 2.3%), respectively. Based on radiological findings, we identified a wide variety of non-TB abnormalities during population-based TB screening. TB prevalence surveys and active case finding activities using mass CXR offer an opportunity to integrate disease screening efforts. National Institute for Health Research (IMPALA-grant reference 16/136/35).

Sections du résumé

BACKGROUND
The prevalence of diseases other than TB detected during chest X-ray (CXR) screening is unknown in sub-Saharan Africa. This represents a missed opportunity for identification and treatment of potentially significant disease. Our aim was to describe and quantify non-TB abnormalities identified by TB-focused CXR screening during the 2016 Kenya National TB Prevalence Survey.
METHODS
We reviewed a random sample of 1140 adult (≥15 years) CXRs classified as 'abnormal, suggestive of TB' or 'abnormal other' during field interpretation from the TB prevalence survey. Each image was read (blinded to field classification and study radiologist read) by two expert radiologists, with images classified into one of four major anatomical categories and primary radiological findings. A third reader resolved discrepancies. Prevalence and 95% CIs of abnormalities diagnosis were estimated.
FINDINGS
Cardiomegaly was the most common non-TB abnormality at 259 out of 1123 (23.1%, 95% CI 20.6% to 25.6%), while cardiomegaly with features of cardiac failure occurred in 17 out of 1123 (1.5%, 95% CI 0.9% to 2.4%). We also identified chronic pulmonary pathology including suspected COPD in 3.2% (95% CI 2.3% to 4.4%) and non-specific patterns in 4.6% (95% CI 3.5% to 6.0%). Prevalence of active-TB and severe post-TB lung changes was 3.6% (95% CI 2.6% to 4.8%) and 1.4% (95% CI 0.8% to 2.3%), respectively.
INTERPRETATION
Based on radiological findings, we identified a wide variety of non-TB abnormalities during population-based TB screening. TB prevalence surveys and active case finding activities using mass CXR offer an opportunity to integrate disease screening efforts.
FUNDING
National Institute for Health Research (IMPALA-grant reference 16/136/35).

Identifiants

pubmed: 33504563
pii: thoraxjnl-2020-216123
doi: 10.1136/thoraxjnl-2020-216123
pmc: PMC8223623
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

607-614

Subventions

Organisme : Wellcome Trust
ID : 206575/Z/17/Z
Pays : United Kingdom

Investigateurs

Emmanuel Addo-Yobo (E)
Brian Allwood (B)
Hastings Banda (H)
Imelda Bates (I)
Amsalu Binegdie (A)
Asma El Sony (AE)
Adegoke Falade (A)
Jahangir Khan (J)
Maia Lesosky (M)
Bertrand Mbatchou (B)
Hellen Meme (H)
Kevin Mortimer (K)
Beatrice Mutayoba (B)
Louis Niessen (L)
Nyanda Elias Ntinginya (NE)
Jamie Rylance (J)
Miriam Taegtmeyer (M)
Rachel Tolhurst (R)
William Worodria (W)
Heather Zar (H)
Eliya Zulu (E)
Lindsay Zurba (L)

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

PLoS One. 2018 Dec 26;13(12):e0209098
pubmed: 30586448
Ghana Med J. 2015 Sep;49(3):159-64
pubmed: 26693191
Cardiovasc J Afr. 2015 Mar-Apr;26(2 Suppl 1):S6-10
pubmed: 25962950
Public Health Action. 2019 Dec 21;9(4):166-168
pubmed: 32042609
PLoS One. 2012;7(7):e38691
pubmed: 22792158
Int J Tuberc Lung Dis. 2013 May;17(5):583-9
pubmed: 23394105
Glob Health Action. 2019;12(1):1646024
pubmed: 31500551
Can Med Assoc J. 1966 Jun 11;94(24):1257-61
pubmed: 5911154
Sci Rep. 2018 Aug 17;8(1):12339
pubmed: 30120345
Lancet Infect Dis. 2014 Sep;14(9):794-5
pubmed: 25164190
BMC Infect Dis. 2014 Oct 19;14:532
pubmed: 25326816
Radiology. 2008 Mar;246(3):697-722
pubmed: 18195376
Thorax. 2020 Mar;75(3):269-278
pubmed: 32102951
Sci Rep. 2020 Mar 26;10(1):5492
pubmed: 32218458
Int J Tuberc Lung Dis. 2008 Nov;12(11):1255-60
pubmed: 18926034
PLoS One. 2016 Oct 4;11(10):e0163490
pubmed: 27701421
PLoS One. 2016 Aug 12;11(8):e0161176
pubmed: 27518438
Proc R Soc Med. 1949 Dec;42(12):1039-44
pubmed: 15399919
Int J Tuberc Lung Dis. 2012 Nov;16(11):1421-2
pubmed: 23044441

Auteurs

Brenda Nyambura Mungai (BN)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK brendanyambura2013@gmail.com.

Elizabeth Joekes (E)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Worldwide Radiology, Liverpool, UK.

Enos Masini (E)

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.
Stop TB Partnership, Geneva, Switzerland.

Angela Obasi (A)

Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
Axess Sexual Health, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.

Veronica Manduku (V)

Kenya Medical Research Institute, Nairobi, Kenya.

Beatrice Mugi (B)

Kenyatta National Hospital, Nairobi, Kenya.

Jane Ong'angò (J)

Kenya Medical Research Institute, Nairobi, Kenya.

Dickson Kirathe (D)

Division of National Tuberculosis, Leprosy and Lung Disease Program, Nairobi, Kenya.

Richard Kiplimo (R)

Division of National Tuberculosis, Leprosy and Lung Disease Program, Nairobi, Kenya.

Joseph Sitienei (J)

Division of National Tuberculosis, Leprosy and Lung Disease Program, Nairobi, Kenya.

Rose Oronje (R)

African Institute for Development Policy, Nairobi, Kenya.

Ben Morton (B)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Critical Care, Liverpool University Hospitals NHS Foundation Trust, Liverpool, Liverpool, UK.

Stephen Bertel Squire (SB)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Tropical & Infectious Diseases Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.

Peter MacPherson (P)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH